Odimma Therapeutics
Company Details
Status: Private
Employees: 1-10
Location:
Grandest, France
Type:
sample
Technology:
sample
sample
sample
sample
sample
sample
sample
About: Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy.
Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients.
Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique.
By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has designed a next-generation personalized immunization platform that brings a sustainable therapeutic solution to fight the most hard-to-treat cancers.
Carried by a team of experts and a supportive environment, we are now preparing our upcoming entry in the clinic
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Odimma Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.